SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH M impact

AstraZeneca Made Roughly $10B Offer for Rhythm Pharmaceuticals, Sources Say

The Wall Street Journal reports, citing sources, that AstraZeneca made an offer of roughly $10 billion for Rhythm Pharmaceuticals.

AZNRYTM
SquawkNews Desk 2 updates Updated Nov 04, 2026, 09:00 PM UTC

Story updates

08:57:26 PM UTC
SquawkNews
AstraZeneca Made $124 Per Share Offer for Rhythm Pharmaceuticals Last Month, Sources Say — WSJ
09:00:27 PM UTC
SquawkNews
ASTRAZENECA OFFERED TO PAY $124 A SHARE FOR THE RHYTHM PHARMACEUTICALS LAST MONTH- WSJ

Related stories

Evommune Licenses Hinova Autoimmune Drug in Deal Worth Up to $1.1 Billion Evommune said it licensed rights to an experimental autoimmune disease treatment from China's Hinova Pharmaceuticals, with up to about $1.1 billion in milestone payments. M impact | MNA | Nov 04, 2026, 10:24 PM UTC AstraZeneca Offers for Rhythm, Sources Say AstraZeneca made an offer for Rhythm, according to sources. M impact | MNA | Nov 04, 2026, 10:20 PM UTC Dover Completes Acquisition of Leistung Engineering Dover completed its acquisition of Leistung Engineering on November 4, 2026. M impact | MNA | Nov 04, 2026, 10:10 PM UTC Agility Robotics, Churchill Capital XI Complete Business Combination Agility Robotics completed its business combination with Churchill Capital Corp XI. M impact | MNA | Nov 04, 2026, 09:32 PM UTC Corpay Completes Sale of UK Vehicle Maintenance Business Corpay completed the sale of its UK vehicle maintenance business to OEConnection. M impact | MNA | Nov 04, 2026, 09:03 PM UTC Corpay Completes Sale of UK Vehicle Maintenance Business to OEConnection Corpay completed the sale of its UK vehicle maintenance business to OEConnection. M impact | MNA | Nov 04, 2026, 09:01 PM UTC